We've found
8,085
archived clinical trials in
Cervical Cancer
We've found
8,085
archived clinical trials in
Cervical Cancer
Study of Psychosexual Impact of Cancer-Related Infertility in Women: Third Party Reproductive Assistance
Updated: 7/7/2015
Cross-Sectional Study of Psychosexual Impact of Cancer-Related Infertility in Women: Third Party Reproductive Assistance
Status: Enrolling
Updated: 7/7/2015
Study of Psychosexual Impact of Cancer-Related Infertility in Women: Third Party Reproductive Assistance
Updated: 7/7/2015
Cross-Sectional Study of Psychosexual Impact of Cancer-Related Infertility in Women: Third Party Reproductive Assistance
Status: Enrolling
Updated: 7/7/2015
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
Updated: 7/13/2015
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
Updated: 7/13/2015
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
Updated: 7/13/2015
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
Updated: 7/13/2015
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
Updated: 7/13/2015
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
Updated: 7/13/2015
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
Updated: 7/13/2015
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
Updated: 7/13/2015
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
Updated: 7/13/2015
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
Updated: 7/13/2015
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
Updated: 7/13/2015
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
Updated: 7/13/2015
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
Updated: 7/13/2015
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
Updated: 7/13/2015
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
Updated: 7/13/2015
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
Updated: 7/13/2015
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
Updated: 7/13/2015
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
Updated: 7/13/2015
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
Updated: 7/13/2015
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
Updated: 7/13/2015
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
Updated: 7/13/2015
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
Updated: 7/13/2015
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
Updated: 7/13/2015
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
Updated: 7/13/2015
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
Updated: 7/13/2015
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
Updated: 7/13/2015
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
Updated: 7/13/2015
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
Updated: 7/13/2015
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
Updated: 7/13/2015
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
Updated: 7/13/2015
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
Updated: 7/13/2015
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
Updated: 7/13/2015
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
Updated: 7/13/2015
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
Updated: 7/13/2015
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
Updated: 7/13/2015
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
Updated: 7/13/2015
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
Updated: 7/13/2015
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
Updated: 7/13/2015
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
Updated: 7/13/2015
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
Updated: 7/13/2015
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
Updated: 7/13/2015
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
Updated: 7/13/2015
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
Updated: 7/13/2015
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
Updated: 7/13/2015
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
Updated: 7/13/2015
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
Updated: 7/13/2015
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
Updated: 7/13/2015
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
Updated: 7/13/2015
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
Updated: 7/13/2015
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
Updated: 7/13/2015
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
Updated: 7/13/2015
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
Updated: 7/13/2015
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
Updated: 7/13/2015
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
Updated: 7/13/2015
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
Updated: 7/13/2015
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
Updated: 7/13/2015
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
Updated: 7/13/2015
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
Updated: 7/13/2015
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
Updated: 7/13/2015
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
Updated: 7/13/2015
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
Updated: 7/13/2015
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
Updated: 7/13/2015
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
Updated: 7/13/2015
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
Updated: 7/13/2015
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Click here to add this to my saved trials
Electronic Patient Reported Symptom Assessment
Updated: 7/13/2015
Electronic Patient Reported Symptom Assessment: A Pilot Study Introducing Advanced Care Planning and Palliative Care to Hospitalized Women With Advanced Gynecologic, Breast, Thoracic, or Gastrointestinal Malignancies.
Status: Enrolling
Updated: 7/13/2015
Electronic Patient Reported Symptom Assessment
Updated: 7/13/2015
Electronic Patient Reported Symptom Assessment: A Pilot Study Introducing Advanced Care Planning and Palliative Care to Hospitalized Women With Advanced Gynecologic, Breast, Thoracic, or Gastrointestinal Malignancies.
Status: Enrolling
Updated: 7/13/2015
Click here to add this to my saved trials
Feasibility Study of the Xoft® Axxent® Electronic Brachytherapy System for the Treatment of Cervical Cancer
Updated: 7/17/2015
Feasibility Study of the Xoft® Axxent® Electronic Brachytherapy System for the Treatment of Cervical Cancer
Status: Enrolling
Updated: 7/17/2015
Feasibility Study of the Xoft® Axxent® Electronic Brachytherapy System for the Treatment of Cervical Cancer
Updated: 7/17/2015
Feasibility Study of the Xoft® Axxent® Electronic Brachytherapy System for the Treatment of Cervical Cancer
Status: Enrolling
Updated: 7/17/2015
Click here to add this to my saved trials
Breast and Cervical Cancer Educational Intervention for Latinas in Western New York
Updated: 7/21/2015
Investigating a Breast and Cervical Cancer Intervention for Latinas in Western New York
Status: Enrolling
Updated: 7/21/2015
Breast and Cervical Cancer Educational Intervention for Latinas in Western New York
Updated: 7/21/2015
Investigating a Breast and Cervical Cancer Intervention for Latinas in Western New York
Status: Enrolling
Updated: 7/21/2015
Click here to add this to my saved trials
Evaluation of Carboplatin/Paclitaxel/Bevacizumab in the Treatment of Advanced Stage Endometrial Carcinoma
Updated: 7/25/2015
A Phase II Study of Carboplatin/Paclitaxel/Bevacizumab in the Treatment of Advanced Stage Endometrial Carcinoma
Status: Enrolling
Updated: 7/25/2015
Evaluation of Carboplatin/Paclitaxel/Bevacizumab in the Treatment of Advanced Stage Endometrial Carcinoma
Updated: 7/25/2015
A Phase II Study of Carboplatin/Paclitaxel/Bevacizumab in the Treatment of Advanced Stage Endometrial Carcinoma
Status: Enrolling
Updated: 7/25/2015
Click here to add this to my saved trials
Carboplatin, Gemcitabine Hydrochloride, and Stereotactic Body Radiation Therapy in Gynecological Cancer
Updated: 8/3/2015
A Phase 1 Study of Carboplatin and Gemcitabine Chemotherapy and Stereotactic Body Radiosurgery for the Palliative Treatment of Persistent or Recurrent Gynecologic Cancer
Status: Enrolling
Updated: 8/3/2015
Carboplatin, Gemcitabine Hydrochloride, and Stereotactic Body Radiation Therapy in Gynecological Cancer
Updated: 8/3/2015
A Phase 1 Study of Carboplatin and Gemcitabine Chemotherapy and Stereotactic Body Radiosurgery for the Palliative Treatment of Persistent or Recurrent Gynecologic Cancer
Status: Enrolling
Updated: 8/3/2015
Click here to add this to my saved trials
Feasibility Study: Accuracy of Biomarker in Detection of Endometrial Cancer
Updated: 8/3/2015
Feasibility Clinical Study: Accuracy of the P2X7 Biomarker in Detection of Endometrial Cancers in Women
Status: Enrolling
Updated: 8/3/2015
Feasibility Study: Accuracy of Biomarker in Detection of Endometrial Cancer
Updated: 8/3/2015
Feasibility Clinical Study: Accuracy of the P2X7 Biomarker in Detection of Endometrial Cancers in Women
Status: Enrolling
Updated: 8/3/2015
Click here to add this to my saved trials
Feasibility Study: Accuracy of Biomarker in Detection of Endometrial Cancer
Updated: 8/3/2015
Feasibility Clinical Study: Accuracy of the P2X7 Biomarker in Detection of Endometrial Cancers in Women
Status: Enrolling
Updated: 8/3/2015
Feasibility Study: Accuracy of Biomarker in Detection of Endometrial Cancer
Updated: 8/3/2015
Feasibility Clinical Study: Accuracy of the P2X7 Biomarker in Detection of Endometrial Cancers in Women
Status: Enrolling
Updated: 8/3/2015
Click here to add this to my saved trials
Feasibility Study: Accuracy of Biomarker in Detection of Endometrial Cancer
Updated: 8/3/2015
Feasibility Clinical Study: Accuracy of the P2X7 Biomarker in Detection of Endometrial Cancers in Women
Status: Enrolling
Updated: 8/3/2015
Feasibility Study: Accuracy of Biomarker in Detection of Endometrial Cancer
Updated: 8/3/2015
Feasibility Clinical Study: Accuracy of the P2X7 Biomarker in Detection of Endometrial Cancers in Women
Status: Enrolling
Updated: 8/3/2015
Click here to add this to my saved trials
Feasibility Study: Accuracy of Biomarker in Detection of Endometrial Cancer
Updated: 8/3/2015
Feasibility Clinical Study: Accuracy of the P2X7 Biomarker in Detection of Endometrial Cancers in Women
Status: Enrolling
Updated: 8/3/2015
Feasibility Study: Accuracy of Biomarker in Detection of Endometrial Cancer
Updated: 8/3/2015
Feasibility Clinical Study: Accuracy of the P2X7 Biomarker in Detection of Endometrial Cancers in Women
Status: Enrolling
Updated: 8/3/2015
Click here to add this to my saved trials
Feasibility Study: Accuracy of Biomarker in Detection of Endometrial Cancer
Updated: 8/3/2015
Feasibility Clinical Study: Accuracy of the P2X7 Biomarker in Detection of Endometrial Cancers in Women
Status: Enrolling
Updated: 8/3/2015
Feasibility Study: Accuracy of Biomarker in Detection of Endometrial Cancer
Updated: 8/3/2015
Feasibility Clinical Study: Accuracy of the P2X7 Biomarker in Detection of Endometrial Cancers in Women
Status: Enrolling
Updated: 8/3/2015
Click here to add this to my saved trials
Study of Zoledronic Acid Versus Observation on Bone Mineral Density and Incidence of Micrometastasis in Women Undergoing Pelvic Radiation for Cervical Cancer
Updated: 8/10/2015
Randomized Phase II Study of Zoledronic Acid vs Observation on Bone Mineral Density and Incidence of Micrometastasis in Women Undergoing Pelvic Radiation for Cervical Cancer
Status: Enrolling
Updated: 8/10/2015
Study of Zoledronic Acid Versus Observation on Bone Mineral Density and Incidence of Micrometastasis in Women Undergoing Pelvic Radiation for Cervical Cancer
Updated: 8/10/2015
Randomized Phase II Study of Zoledronic Acid vs Observation on Bone Mineral Density and Incidence of Micrometastasis in Women Undergoing Pelvic Radiation for Cervical Cancer
Status: Enrolling
Updated: 8/10/2015
Click here to add this to my saved trials
Pelvic IMRT With Tomotherapy: A Phase I Feasibility Study in Post-Hysterectomy Cervical Cancer Patients
Updated: 8/14/2015
Pelvic IMRT With Tomotherapy: A Phase I Feasibility Study in Post-Hysterectomy Cervical Cancer Patients
Status: Enrolling
Updated: 8/14/2015
Pelvic IMRT With Tomotherapy: A Phase I Feasibility Study in Post-Hysterectomy Cervical Cancer Patients
Updated: 8/14/2015
Pelvic IMRT With Tomotherapy: A Phase I Feasibility Study in Post-Hysterectomy Cervical Cancer Patients
Status: Enrolling
Updated: 8/14/2015
Click here to add this to my saved trials
Bupropion in Helping Adults Stop Smoking
Updated: 8/27/2015
A Phase II Study of the Effects of Extended Pre-Cessation Bupropion for Smoking Cessation
Status: Enrolling
Updated: 8/27/2015
Bupropion in Helping Adults Stop Smoking
Updated: 8/27/2015
A Phase II Study of the Effects of Extended Pre-Cessation Bupropion for Smoking Cessation
Status: Enrolling
Updated: 8/27/2015
Click here to add this to my saved trials
Safety Study of Suprachoroidal Triamcinolone Acetonide Via Microneedle to Treat Uveitis
Updated: 8/31/2015
Open-Label, Safety and Tolerability Study of Suprachoroidal Triamcinolone Acetonide Via Microneedle in Subjects With Non-Infectious Uveitis
Status: Enrolling
Updated: 8/31/2015
Safety Study of Suprachoroidal Triamcinolone Acetonide Via Microneedle to Treat Uveitis
Updated: 8/31/2015
Open-Label, Safety and Tolerability Study of Suprachoroidal Triamcinolone Acetonide Via Microneedle in Subjects With Non-Infectious Uveitis
Status: Enrolling
Updated: 8/31/2015
Click here to add this to my saved trials
Safety Study of Suprachoroidal Triamcinolone Acetonide Via Microneedle to Treat Uveitis
Updated: 8/31/2015
Open-Label, Safety and Tolerability Study of Suprachoroidal Triamcinolone Acetonide Via Microneedle in Subjects With Non-Infectious Uveitis
Status: Enrolling
Updated: 8/31/2015
Safety Study of Suprachoroidal Triamcinolone Acetonide Via Microneedle to Treat Uveitis
Updated: 8/31/2015
Open-Label, Safety and Tolerability Study of Suprachoroidal Triamcinolone Acetonide Via Microneedle in Subjects With Non-Infectious Uveitis
Status: Enrolling
Updated: 8/31/2015
Click here to add this to my saved trials
Safety Study of Suprachoroidal Triamcinolone Acetonide Via Microneedle to Treat Uveitis
Updated: 8/31/2015
Open-Label, Safety and Tolerability Study of Suprachoroidal Triamcinolone Acetonide Via Microneedle in Subjects With Non-Infectious Uveitis
Status: Enrolling
Updated: 8/31/2015
Safety Study of Suprachoroidal Triamcinolone Acetonide Via Microneedle to Treat Uveitis
Updated: 8/31/2015
Open-Label, Safety and Tolerability Study of Suprachoroidal Triamcinolone Acetonide Via Microneedle in Subjects With Non-Infectious Uveitis
Status: Enrolling
Updated: 8/31/2015
Click here to add this to my saved trials
Magnetic Resonance Elastography (MRE) of Uterine Fibroids
Updated: 9/1/2015
Magnetic Resonance Elastography (MRE) of Uterine Fibroids
Status: Enrolling
Updated: 9/1/2015
Magnetic Resonance Elastography (MRE) of Uterine Fibroids
Updated: 9/1/2015
Magnetic Resonance Elastography (MRE) of Uterine Fibroids
Status: Enrolling
Updated: 9/1/2015
Click here to add this to my saved trials